☰

Chris King, Ph.D. - Publications

Affiliations: 
Biochemistry University of Washington, Seattle, Seattle, WA 
Area:
protein structure prediction
Tree Info Similar researchers PubMed Report error

31 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Dang AT, Levin-Epstein RG, Shabsovich D, Cao M, King C, Chu FI, Mantz CA, Stephans KL, Reddy CA, Loblaw DA, Cheung P, Scorsetti M, Cozzi L, DeNittis AS, Wang Y, et al. Gantry-Mounted Linear Accelerator-Based Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Cancer. Advances in Radiation Oncology. 5: 404-411. PMID 32529134 DOI: 10.1016/J.Adro.2019.09.010  0.351
2020 Kishan A, Karnes RJ, Romero T, Motterle G, Tendulkar R, Klein E, Wong JK, Horwitz E, Tward J, Dess R, Wedde T, Lilleby W, Merrick G, Stock R, Krauss D, ... ... King C, et al. Pd63-03 Treatment Intensification And Outcome In High-Risk Prostate Cancer: A Multi-Institutional Consortium Analysis The Journal of Urology. 203. DOI: 10.1097/Ju.0000000000000980.03  0.303
2020 Valle L, Ruan D, Dang A, Levin-Epstein R, Patel A, Weidhaas J, Nickols N, Lee P, Low D, Qi S, King C, Steinberg M, Kupelian P, Cao M, Kishan A. Development and Validation of a Comprehensive Multivariate Dosimetric Model for Predicting Late Genitourinary Toxicity Following Prostate Cancer Stereotactic Body Radiotherapy International Journal of Radiation Oncology Biology Physics. 108. DOI: 10.1016/J.Ijrobp.2020.02.626  0.347
2019 Kishan AU, Tyran M, Weng J, Upadhyaya S, Lamb J, Steinberg M, King C, Cao M. Stereotactic body radiotherapy to the prostate and pelvic lymph nodes: A detailed dosimetric analysis of a phase II prospective trial. The British Journal of Radiology. 20181001. PMID 30912957 DOI: 10.1259/Bjr.20181001  0.305
2019 Jiang N, Dang A, Yuan Y, Chu F, King C, Collins S, Aghdam N, Suy S, Miszczyk L, Mantz C, Bagshaw H, Buyyounouski M, Steinberg M, Kupelian P, Kishan A. Evaluating Prostate-Specific Antigen (PSA) Nadir and Bounce After Stereotactic Body Radiotherapy (SBRT) in a Multi-Institutional Cohort International Journal of Radiation Oncology Biology Physics. 103. DOI: 10.1016/S0360-3016(19)30440-7  0.347
2017 Wang C, Kamrava M, King C, Steinberg ML. Racial Disparity in Prostate Cancer-Specific Mortality for High-Risk Prostate Cancer: A Population-Based Study. Cureus. 9: e961. PMID 28168138 DOI: 10.7759/Cureus.961  0.353
2017 Crook ZR, Bradley P, Sevilla G, Friend D, King C, Mhyre A, Strong R, Baker D, Olson JM. Abstract 5573: A high-affinity Optide (optimized peptide) inhibitor of the Hippo pathway’s YAP-TEAD interaction Cancer Research. 77: 5573-5573. DOI: 10.1158/1538-7445.Am2017-5573  0.374
2016 Qi XS, Wang JP, Gomez CL, Shao W, Xu X, King C, Low DA, Steinberg M, Kupelian P. Plan quality and dosimetric association of patient-reported rectal and urinary toxicities for prostate stereotactic body radiotherapy. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 27587270 DOI: 10.1016/J.Radonc.2016.08.012  0.343
2016 Hegde JV, Collins SP, Fuller DB, King CR, Demanes DJ, Wang PC, Kupelian PA, Steinberg ML, Kamrava M. A Pooled Analysis of Biochemical Failure in Intermediate-risk Prostate Cancer Following Definitive Stereotactic Body Radiotherapy (SBRT) or High-Dose-Rate Brachytherapy (HDR-B) Monotherapy. American Journal of Clinical Oncology. PMID 27322703 DOI: 10.1097/Coc.0000000000000311  0.348
2016 Crook ZR, Bradley P, King C, Mhyre AJ, Baker D, Olson JM. Abstract 2971: Optides (optimized knottin peptides) computationally designed to target the oncogenic HIPPO pathway Cancer Research. 76: 2971-2971. DOI: 10.1158/1538-7445.Am2016-2971  0.381
2015 Kupelian P, Mehta NH, King C, Steinberg M, Finkelstein SE, Fernandez E. Stereotactic body radiation therapy for prostate cancer: Rational and reasonable. Practical Radiation Oncology. 5: 188-92. PMID 25413392 DOI: 10.1016/J.Prro.2014.08.018  0.396
2014 Dong P, Nguyen D, Ruan D, King C, Long T, Romeijn E, Low DA, Kupelian P, Steinberg M, Yang Y, Sheng K. Feasibility of prostate robotic radiation therapy on conventional C-arm linacs. Practical Radiation Oncology. 4: 254-60. PMID 25012834 DOI: 10.1016/J.Prro.2013.10.009  0.331
2014 Mazor R, Eberle JA, Hu X, Vassall AN, Onda M, Beers R, Lee EC, Kreitman RJ, Lee B, Baker D, King C, Hassan R, Benhar I, Pastan I. Recombinant immunotoxin for cancer treatment with low immunogenicity by identification and silencing of human T-cell epitopes. Proceedings of the National Academy of Sciences of the United States of America. 111: 8571-6. PMID 24799704 DOI: 10.1073/Pnas.1405153111  0.403
2014 Wang P, Xu X, Qi S, King C, Kamrava M, Tenn S, Kupelian P. PO-0722: Dosimetric parameters correlated to quality of life after stereotactic body radiation therapy for prostate cancer Radiotherapy and Oncology. 111: S29-S30. DOI: 10.1016/S0167-8140(15)30840-9  0.345
2014 Gomez CL, Xu X, Qi X, Wang P, Kupelian P, Steinberg M, King C. Dosimetric Parameters Predict Quality of Life Outcomes for Patients Receiving Stereotactic Body Radiation Therapy for Prostate Cancer International Journal of Radiation Oncology Biology Physics. 90. DOI: 10.1016/J.Ijrobp.2014.05.1330  0.35
2013 Dong P, Nguyen D, Ruan D, Romeijn E, Long T, Kupelian P, Yang Y, Low D, King C, Steinberg M, Sheng K. SU-E-T-657: Prostate Robotic Radiotherapy On Conventional C-Arm Linacs. Medical Physics. 40: 357. PMID 28519461 DOI: 10.1118/1.4815084  0.314
2012 Nagarajan R, Margolis D, Raman S, Sheng K, King C, Reiter R, Thomas MA. Correlation of Gleason scores with diffusion-weighted imaging findings of prostate cancer. Advances in Urology. 2012: 374805. PMID 22216026 DOI: 10.1155/2012/374805  0.305
2012 Agazaryan N, Sharma G, Kupelian P, Steinberg M, King C. TU-G-BRA-05: Intra-Fraction Motion Management for Prostate SBRT: Clinical Experience and Imaging Frequency Analysis Medical Physics. 39: 3922-3922. DOI: 10.1118/1.4736009  0.31
2012 Katz A, Freeman D, Aronovitz J, Fuller D, Bolzicco G, Meier R, Collins S, Wang J, Steinberg M, King C. Five-year Biochemical Control Rates for Stereotactic Body Radiation Therapy for Organ-confined Prostate Cancer: A Multi-institutional Pooled Analysis International Journal of Radiation Oncology Biology Physics. 84. DOI: 10.1016/J.Ijrobp.2012.07.381  0.344
2011 King C. Stereotactic body radiotherapy for prostate cancer: current results of a phase II trial. Frontiers of Radiation Therapy and Oncology. 43: 428-437. PMID 21625167 DOI: 10.1159/000322507  0.347
2010 King CA, Bradley P. Structure-based prediction of protein-peptide specificity in rosetta Proteins: Structure, Function and Bioinformatics. 78: 3437-3449. PMID 20954182 DOI: 10.1002/prot.22851  0.431
2010 Agazaryan N, Tenn S, Chow P, Lee C, Lee P, Steinberg M, King C. Volumetric Modulated Arc Therapy Treatment Protocol for Hypo-fractionated Stereotactic Body Radiotherapy for Localized Prostate Cancer International Journal of Radiation Oncology*Biology*Physics. 78: S844. DOI: 10.1016/J.Ijrobp.2010.07.1953  0.309
2008 Xie Y, Djajaputra D, King C, Hossain S, Ma L, Xing L. TU-FF-A3-04: Intrafraction Motion of Prostate in Cyberknife Hypofractionated Radiotherapy Medical Physics. 35: 2922-2922. DOI: 10.1118/1.2962653  0.346
2008 Mao W, Riaz N, Lee K, Wiersma R, King C, Hsu A, Luxton G, Xing L. SU-DD-A3-03: Using Treatment Beam Imaging to Monitor Prostate Motion In Near Real-Time On a Conventional LINAC Medical Physics. 35: 2634-2634. DOI: 10.1118/1.2961364  0.32
2008 Dua N, Mao W, Lee L, Riaz N, Wiersma R, Hsu A, Luxton G, King C, Xing L. Using MV Treatment Beam Imaging to Monitor Prostate Motion in Near Real-time on a Conventional LINAC International Journal of Radiation Oncology*Biology*Physics. 72: S560-S561. DOI: 10.1016/J.Ijrobp.2008.06.128  0.316
2007 Pawlicki T, Cotrutz C, King C. Prostate cancer therapy with stereotactic body radiation therapy. Frontiers of Radiation Therapy and Oncology. 40: 395-406. PMID 17641522 DOI: 10.1159/000106049  0.373
2007 Pachynski RK, King C, Srinivas S. Prostate specific antigen doubling time (PSADT) in patients with hormone refractory prostate cancer (HRPC) undergoing docetaxel chemotherapy as a predictor of overall survival Journal of Clinical Oncology. 25: 15556-15556. DOI: 10.1200/Jco.2007.25.18_Suppl.15556  0.348
2006 Hsu A, Pawlicki T, King C, Hancock S, Luxton G. TU-E-ValB-04: Impact On Nodal Dose Distribution From Daily Fiducial Tracking for IMRT Prostate and Pelvic Node Treatments Medical Physics. 33: 2216-2216. DOI: 10.1118/1.2241632  0.341
2006 Hara W, Patel D, Pawlicki T, Cotrutz C, Presti J, King C. 2206 : Hypofractionated Stereotactic Radiotherapy for Prostate Cancer: Early Results International Journal of Radiation Oncology Biology Physics. 66. DOI: 10.1016/J.Ijrobp.2006.07.612  0.347
2005 Pawlicki T, Kim G, King C, Xing L, Boyer A, Luxton G. Investigation of Linac-based Image-guided Hypofractionated Prostate Treatment International Journal of Radiation Oncology*Biology*Physics. 63: S518. DOI: 10.1016/J.Ijrobp.2005.07.876  0.336
2001 Siu W, Kapp DS, Wren SM, King C, Terris MK. External beam radiotherapy for synchronous rectal and prostatic tumors. Urology. 57: 800. PMID 11306416 DOI: 10.1016/S0090-4295(00)01126-2  0.351
Show low-probability matches.